FAV-201

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFAV-201
Drug Alias NameT-cell lymphoma vaccineTorrexFAV-201
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLymphoma, T-Cell, Cutaneous
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMmrglobal
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMmrglobal
Active IndicationsN/A
Inactive IndicationsLymphoma, T-Cell, Cutaneous

Other Information

ATC CodeN/A
Related LinksDrugBank